CN104725279A - 一种N-Boc-联苯丙氨酸衍生物的制备方法 - Google Patents
一种N-Boc-联苯丙氨酸衍生物的制备方法 Download PDFInfo
- Publication number
- CN104725279A CN104725279A CN201510072947.8A CN201510072947A CN104725279A CN 104725279 A CN104725279 A CN 104725279A CN 201510072947 A CN201510072947 A CN 201510072947A CN 104725279 A CN104725279 A CN 104725279A
- Authority
- CN
- China
- Prior art keywords
- compound
- preparation
- reaction
- solvent
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 150000001875 compounds Chemical class 0.000 claims abstract description 38
- 150000008065 acid anhydrides Chemical class 0.000 claims abstract description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 28
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 27
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 21
- 238000001816 cooling Methods 0.000 claims description 18
- 238000002425 crystallisation Methods 0.000 claims description 18
- 230000008025 crystallization Effects 0.000 claims description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- 239000003513 alkali Substances 0.000 claims description 9
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 8
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 4
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- 235000012538 ammonium bicarbonate Nutrition 0.000 claims description 4
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 3
- 239000005695 Ammonium acetate Substances 0.000 claims description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 3
- 235000019257 ammonium acetate Nutrition 0.000 claims description 3
- 229940043376 ammonium acetate Drugs 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 239000001632 sodium acetate Substances 0.000 claims description 3
- 235000017281 sodium acetate Nutrition 0.000 claims description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 2
- 239000003054 catalyst Substances 0.000 claims description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 2
- 235000015320 potassium carbonate Nutrition 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims 2
- 238000000034 method Methods 0.000 abstract description 4
- 238000009833 condensation Methods 0.000 abstract description 3
- 230000005494 condensation Effects 0.000 abstract description 3
- 230000009467 reduction Effects 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 2
- ZCDNRPPFBQDQHR-SSYATKPKSA-N Syrosingopine Chemical compound C1=C(OC)C(OC(=O)OCC)=C(OC)C=C1C(=O)O[C@H]1[C@H](OC)[C@@H](C(=O)OC)[C@H]2C[C@@H]3C(NC=4C5=CC=C(OC)C=4)=C5CCN3C[C@H]2C1 ZCDNRPPFBQDQHR-SSYATKPKSA-N 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 22
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 15
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 15
- 238000004128 high performance liquid chromatography Methods 0.000 description 14
- 239000004305 biphenyl Substances 0.000 description 8
- 235000010290 biphenyl Nutrition 0.000 description 8
- 229960000935 dehydrated alcohol Drugs 0.000 description 8
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 5
- JCZLABDVDPYLRZ-AWEZNQCLSA-N biphenylalanine Chemical compound C1=CC(C[C@H](N)C(O)=O)=CC=C1C1=CC=CC=C1 JCZLABDVDPYLRZ-AWEZNQCLSA-N 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000000967 suction filtration Methods 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 0 *CCc(cc1)ccc1-*1ccccc1 Chemical compound *CCc(cc1)ccc1-*1ccccc1 0.000 description 4
- ALBSWLMUHHZLLR-UHFFFAOYSA-N methyl 2-nitroacetate Chemical class COC(=O)C[N+]([O-])=O ALBSWLMUHHZLLR-UHFFFAOYSA-N 0.000 description 4
- 239000007858 starting material Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 2
- 239000002792 enkephalinase inhibitor Substances 0.000 description 2
- 229960004756 ethanol Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- GRKXKNLRBZVLSN-UHFFFAOYSA-N methylamino acetate Chemical compound CNOC(C)=O GRKXKNLRBZVLSN-UHFFFAOYSA-N 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- JFTHBDBUVHRREF-UHFFFAOYSA-N 2-acetamidopropanedioic acid Chemical compound CC(=O)NC(C(O)=O)C(O)=O JFTHBDBUVHRREF-UHFFFAOYSA-N 0.000 description 1
- OQFQFABNLBMQMD-UHFFFAOYSA-N CC(C)(C)OC(NC(Cc(cc1)ccc1C1=CCCC=C1)CO)=O Chemical compound CC(C)(C)OC(NC(Cc(cc1)ccc1C1=CCCC=C1)CO)=O OQFQFABNLBMQMD-UHFFFAOYSA-N 0.000 description 1
- 229940122586 Enkephalinase inhibitor Drugs 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- -1 biphenyl benzyl haloalkane Chemical class 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510072947.8A CN104725279B (zh) | 2015-02-12 | 2015-02-12 | 一种N‑Boc‑联苯丙氨酸衍生物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510072947.8A CN104725279B (zh) | 2015-02-12 | 2015-02-12 | 一种N‑Boc‑联苯丙氨酸衍生物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104725279A true CN104725279A (zh) | 2015-06-24 |
CN104725279B CN104725279B (zh) | 2018-03-02 |
Family
ID=53449761
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510072947.8A Active CN104725279B (zh) | 2015-02-12 | 2015-02-12 | 一种N‑Boc‑联苯丙氨酸衍生物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104725279B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018007919A1 (en) | 2016-07-05 | 2018-01-11 | Novartis Ag | New process for early sacubitril intermediates |
WO2018033866A1 (en) | 2016-08-17 | 2018-02-22 | Novartis Ag | New processes and intermediates for nep inhibitor synthesis |
WO2018116203A1 (en) | 2016-12-23 | 2018-06-28 | Novartis Ag | New process for early sacubitril intermediates |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1155211A (zh) * | 1995-12-12 | 1997-07-23 | 汤姆森消费电子有限公司 | 用于产生可变频率同步信号的方法和装置 |
CN1297453A (zh) * | 1998-04-23 | 2001-05-30 | 诺瓦提斯公司 | 硫醇类内皮缩血管肽转化酶抑制剂 |
CN1472209A (zh) * | 2003-06-18 | 2004-02-04 | 复旦大学 | 氨基/酰基取代β-咔啉及其硫代类似物、制备方法和应用 |
CN101370943A (zh) * | 2006-01-17 | 2009-02-18 | 住友化学株式会社 | 旋光联苯基丙氨酸化合物或其盐或酯的制备方法 |
CN101484445A (zh) * | 2006-07-07 | 2009-07-15 | 皮瑞缪生命科学有限公司 | 吡咯烷取代的黄酮的对映选择性合成 |
CN101547893A (zh) * | 2007-03-20 | 2009-09-30 | 住友化学株式会社 | L-联苯丙氨酸化合物的盐的回收方法、以及使用它的联苯丙氨酸酯化合物的回收方法 |
CN101684077A (zh) * | 2008-09-24 | 2010-03-31 | 浙江九洲药业股份有限公司 | N-酰基联苯丙氨酸的制备方法 |
WO2012129792A1 (zh) * | 2011-03-30 | 2012-10-04 | 中国科学院上海药物研究所 | 嘧啶酮类化合物、其制备方法及药物组合物和用途 |
CN102976995A (zh) * | 2012-12-07 | 2013-03-20 | 兰州大学 | 吡咯赖氨酸的手性合成方法 |
-
2015
- 2015-02-12 CN CN201510072947.8A patent/CN104725279B/zh active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1155211A (zh) * | 1995-12-12 | 1997-07-23 | 汤姆森消费电子有限公司 | 用于产生可变频率同步信号的方法和装置 |
CN1297453A (zh) * | 1998-04-23 | 2001-05-30 | 诺瓦提斯公司 | 硫醇类内皮缩血管肽转化酶抑制剂 |
CN1472209A (zh) * | 2003-06-18 | 2004-02-04 | 复旦大学 | 氨基/酰基取代β-咔啉及其硫代类似物、制备方法和应用 |
CN101370943A (zh) * | 2006-01-17 | 2009-02-18 | 住友化学株式会社 | 旋光联苯基丙氨酸化合物或其盐或酯的制备方法 |
CN101484445A (zh) * | 2006-07-07 | 2009-07-15 | 皮瑞缪生命科学有限公司 | 吡咯烷取代的黄酮的对映选择性合成 |
CN101547893A (zh) * | 2007-03-20 | 2009-09-30 | 住友化学株式会社 | L-联苯丙氨酸化合物的盐的回收方法、以及使用它的联苯丙氨酸酯化合物的回收方法 |
CN101684077A (zh) * | 2008-09-24 | 2010-03-31 | 浙江九洲药业股份有限公司 | N-酰基联苯丙氨酸的制备方法 |
WO2012129792A1 (zh) * | 2011-03-30 | 2012-10-04 | 中国科学院上海药物研究所 | 嘧啶酮类化合物、其制备方法及药物组合物和用途 |
CN102976995A (zh) * | 2012-12-07 | 2013-03-20 | 兰州大学 | 吡咯赖氨酸的手性合成方法 |
Non-Patent Citations (3)
Title |
---|
ANTONIA M. RASERO-ALMANSA等: "Zirconium Materials from Mixed Dicarboxylate Linkers : Enhancing the Stability for Catalytic Applications", 《CHEMCATCHEM》 * |
RICHARD S. FORNICOLA等: "Convenient preparation of amino acid derivatives with two 13C labels", 《TETRAHEDRON LETTERS》 * |
李敬芬主编: "《药物合成反应》", 31 August 2010, 浙江大学出版社 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018007919A1 (en) | 2016-07-05 | 2018-01-11 | Novartis Ag | New process for early sacubitril intermediates |
WO2018033866A1 (en) | 2016-08-17 | 2018-02-22 | Novartis Ag | New processes and intermediates for nep inhibitor synthesis |
WO2018116203A1 (en) | 2016-12-23 | 2018-06-28 | Novartis Ag | New process for early sacubitril intermediates |
Also Published As
Publication number | Publication date |
---|---|
CN104725279B (zh) | 2018-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102268037B (zh) | 一种草铵膦的纯化工艺 | |
CN103665032B (zh) | 一种草铵膦的制备方法 | |
CN104725279A (zh) | 一种N-Boc-联苯丙氨酸衍生物的制备方法 | |
CN102329277A (zh) | 一种制备帕瑞昔布的方法 | |
CN102627594A (zh) | 无水氮丙啶类化合物的制备方法 | |
CN110283104B (zh) | 一种精氨酸培哚普利的制备方法 | |
CN105037327A (zh) | 一种右旋兰索拉唑无水物的纯化方法 | |
CN104086392A (zh) | 催化合成联苯乙酸的方法 | |
CN108997377B (zh) | 一种e型7-atca的制备方法 | |
CN104725256A (zh) | 一种联苯丙氨酸衍生物的制备方法 | |
CN100549022C (zh) | 制备氟替卡松丙酸酯的方法 | |
CN114539343B (zh) | 一种甘氨胆酸的制备方法 | |
CN105777581A (zh) | 一种顺-1-腈基-4-甲氧基环己基-2-(2,5-二甲基苯基)乙酰胺及其制备方法和应用 | |
CN103483205A (zh) | 一种高纯度盐酸美金刚的制备方法 | |
CN103224437A (zh) | 一种关于氨基酸甲酯盐酸盐的制备 | |
WO2021242807A1 (en) | Methods for preparing methyl (s)-2-amino-3-(4-(2,3-dimethylpyridin-4-yl)phenyl)propionate and hydrochloric acid salts thereof | |
CN102757367A (zh) | 一种混旋苯乙磺酸的拆分工艺 | |
WO2021130163A1 (en) | A process for the synthesis of melphalan | |
CN102070497A (zh) | 氟甲砜霉素的合成方法 | |
CN107001250A (zh) | 一种制备奥当卡替中间体的方法 | |
CN110790690A (zh) | 一种3,4-二氟-2-((苯硫基)甲基)苯甲酸的合成方法 | |
CN104478762B (zh) | N,o-二甲基-n-硝基异脲的制备方法 | |
CN107445856A (zh) | 一种n‑异丙基丙烯酰胺的合成工艺 | |
CN104086394A (zh) | 联苯乙酸的制备方法 | |
CN104030938A (zh) | 盐酸丙帕他莫的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191104 Address after: 264205 Guangzhou East Road South and an East Road East, Wendeng economic and Technological Development Zone, Weihai City, Shandong Province Co-patentee after: WEIHAI DISU PHARMACEUTICAL Co.,Ltd. Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Co-patentee after: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Address before: 264205 Shandong city of Weihai province by the district Gushan Town No. 18 South Road, No. 19 North Road, No. 3 East Road, the west five Co-patentee before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. Patentee before: WEIHAI DISU PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210608 Address after: No.1 Qingdao South Road, Weihai Economic and Technological Development Zone, Shandong Province Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Address before: 264205 Wendeng economic and Technological Development Zone, Weihai City, Shandong Province Patentee before: Dijia Pharmaceutical Group Co.,Ltd. Patentee before: WEIHAI DISU PHARMACEUTICAL Co.,Ltd. Patentee before: DISHA PHARMACEUTICAL GROUP Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP02 | Change in the address of a patent holder |
Address after: 264205 268 Tianrun Road, Wendeng economic and Technological Development Zone, Weihai, Shandong Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Address before: No.1 Qingdao South Road, Weihai Economic and Technological Development Zone, Shandong Province Patentee before: Dijia Pharmaceutical Group Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 264205 268 Tianrun Road, Wendeng economic and Technological Development Zone, Weihai, Shandong Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Address before: No.1 Qingdao South Road, Weihai Economic and Technological Development Zone, Shandong Province Patentee before: Dijia Pharmaceutical Group Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 264205 268 Tianrun Road, Wendeng economic and Technological Development Zone, Weihai, Shandong Patentee after: Dijia Pharmaceutical Group Co.,Ltd. Address before: 264205 268 Tianrun Road, Wendeng economic and Technological Development Zone, Weihai, Shandong Patentee before: Dijia Pharmaceutical Group Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder |